Ashley Krull, Ph.D. Associate Director, Cell Therapy Manufacturing and Engineering James Cancer Hospital Cellular Therapy Laboratory Assistant Professor, Hematology The Ohio State University Columbus, Ohio, United States As 2024 draws to a close, the Editorial Board of the Telegraft is...
Adaeze Ekwe, PhD Junior Associate Editor ISCT ESP Leadership Development Program Cellular therapies have significantly evolved since inception as one of the most innovative and transformative approaches to treat diseases, offering new hope for patients with conditions previously deemed...
Miguel Forte, MD, PhD ISCT President mC4Tx Belgium Cell and gene therapy has come a long way, particularly since 2017 when the fantastic clinical outcomes and patient value that had been reported over the previous 5 year promised a great commercial opportunity with regulatory...
Investor Temperature Check: What’s Hot and What’s Not in CGT? Summary of Key Points from Investor Round Table on May 30th, 2024 by Victoria Zellmer, PhD Business Development Manager US Central Territory – MaxCyte Panelists: Jason Bock, Ph.D., CTMC Nagisa Sakurai, Ph.D., MBA,...
by Travis Byrd, Ph.D Process Development The James Cancer Hospital Cell Therapy Laboratory The Ohio State University Wexner Medical Center In November 2023, the U.S. Food and Drug Administration (FDA) released a statement regarding the observed development of secondary...
Janet Macpherson, PhD Senior Editor Cytiva Australia As the editorial team discussed the September issue of Telegraft, I proposed CAR T-cells for autoimmune disease as the topic of my editorial. Imagine my surprise, when reviewing the submitted content just days before publication,...
Miguel Forte, MD, PhD ISCT President mC4Tx Belgium Forty years ago, Steve Jobs made a visionary speech about the use of computers. People would be using computers all day long! He added that “people would be going to ask themselves, several years down the road, “if this was not always...
Antonio Scatena Director of Sales and Marketing Gateway Analytical, an Aptar Pharma Company Mark Broadley Vice President of Operations BioCentriq Paul Dyer Field Application Scientist Halo Labs Beate Wagner Managing Senior Physician and...
Ludwig R. Frontier Ramos MD MSc MBA DHSc Scientific Marketing and Medical Manager for Macopharma, Atlanta, GA. Associate Researcher, Bioethics Faculty, Universidad Anáhuac México Globalization not only brought the world the advantage of universal access to knowledge but also presents...
The International Society for Cell & Gene Therapy (ISCT) celebrates the recent announcement of the U.S. Food and Drug Administration's (FDA) accelerated approval of Tecelra (afamitresgene autoleucel) for the treatment of adults with unresectable or metastatic synovial sarcoma who have...